About this Event
COVID accelerated the movement of healthcare services closer to the patient than ever before. Telemedicine was embraced by clinicians around the country and pharmacies and new urgent care facilities sprung up everywhere, offering a plethora of new services and tests. Truvian and Pleno are companies that provide important services and tests closer to the point of care of the patient. Both companies have secured top tier venture funding and have entered the stage of full commercialization. Join us at this program where you will gain insight into their respective journeys and where they believe they will be with clinician and patient adoption.
*Please note that this event has a hard capacity limit, so get your RSVP in ASAP!
If you have recently been exposed to and/or tested positive for COVID-19, please refer to the Centers for Disease Control and Prevention guidelines to determine if you should attend this event.
Additionally, if you’re experiencing symptoms of COVID-19 or any other contagious illness, please do not attend. Thank you for your cooperation.
Parking:
The Boardwalk offers free parking to all visitors in the surface lots surrounding all 3 buildings within the complex.
Moderator:
Steve Przesmicki, Partner, Cooley
Steven M. Przesmicki specializes in corporate and securities law, and regularly acts as outside corporate counsel to public and private companies. Steve represent clients on SEC and corporate governance matters, public financings, mergers and acquisitions, IPOs, and venture capital and other private financings. He has represented issuers and underwriters in offerings involving well over $2 billion of securities, and advised clients on M&A transactions ranging in value from under $10 million to up to several billion dollars. Steve has also represented clients in a number of other complex transactions such as debt redemptions, joint ventures, option-exchange tender offers and strategic commercial transactions.
Steve represents clients across multiple industries, including analytics, gaming technology, consumer software, diagnostics, enterprise software, ecommerce, life sciences, medical devices and semiconductor equipment manufacturing. These companies range from start-ups to public companies with over $500 million in annual revenues.
Steve previously led the internal legal department of a public technology company, where he managed seven attorneys. There he was responsible for all of the company's legal affairs, including general corporate governance, SEC and Nasdaq matters, securities/financing transactions, strategic investments, commercial transactions, joint ventures, international operations, real estate and facilities matters, patent and trademark prosecution, mergers and acquisitions, human resources, contests and sweepstakes, and litigation matters. His role also involved active support of the company's accounting, finance, tax, banking, insurance, investor relations, lobbying and business development activities.
Steve has been recognized by The Best Lawyers in America. He was also recognized in the 2013 edition of San Diego Super Lawyers, and the 2014-2016, 2018-2019 editions of Southern California Super Lawyers.
Steve received his law degree, cum laude, from the University of Wisconsin Law School, where he was elected to the Order of the Coif and served as an associate editor of the Wisconsin Law Review. He received a Bachelor's degree in Political Science from the University of Wisconsin, Madison.
Prior to attending law school, Steve served as an officer in the United States Navy.
Steve joined the Firm in 1995 and is resident in the San Diego office.
Panel:
Dena Marrinucci, PhD, Co-Founder & COO, Truvian Health
Dena Marrinucci is a life science executive with a passion for introducing diagnostic technologies with potential to transform human health. She joined the founding team at Truvian in late 2015 to work on development of a disruptive benchtop blood testing solution for the point of care. At Truvian, they are working to reimagine blood testing - making it more convenient, affordable, and actionable for patients. As Chief Operating Officer, Dena oversees portfolio management, business operations, manufacturing, talent & HR, assay development, clinical development, and scientific affairs.
Prior to Truvian, she co-founded Epic Sciences, a liquid biopsy company. During her tenure as Epic’s Chief Scientific Officer, Dena established and ran the Pharma Parntering business, assay development, and laboratory operations (CLIA lab). Their work resulted in the launch of a prostate cancer test which was commercialized by Genomic Health (Exact) in 2015.
In addition to her role at Truvian, Dena serves as a board member on the Executive Committee for Connect.org as well as an advisor for various biotech start-ups.
She was named as the Top 10 Fiercest Women in Life Sciences by Fierce Pharma in 2023, MIT Technology Review's Top 35 Innovators Under 35, Foreign Policy's Top 100 Leading Global Thinkers, and the PharmaVoice 100. Dena also was named a Life Science Catalyst Award winner, gaining recognition from Biocom and San Diego Venture Group as one of 10 individuals sparking meaningful change to human health.She has authored dozens of peer reviewed publications and is an inventor on >30 patents. Dena holds a B.S. in Chemistry from University of Vermont and a Ph.D. from The Scripps Research Institute in Chemical Biology.
Gavin Stone, VP of Product Development, Pleno
Gavin is an electronic engineer by training who, over the past 25 years, has navigated his career into life sciences via the wireless communications and semiconductor industries. He has been with Pleno since its inception and leads product development activities as well as marketing and business development. Previously, Gavin worked at Illumina leading their software product marketing team after Illumina acquired Edico Genome in 2018 for $100 Million. At Edico, he was responsible for the startup company’s marketing, business development and corporate development activities. While at Edico, Gavin helped to set two Guinness World Records and spearheaded efforts to have their ground-breaking product, DRAGEN, be named The Scientist magazine’s number one innovation for 2014. Prior to that, he managed numerous high volume cellular products and software platforms at Broadcom after they acquired Zyray Wireless in 2004 for $100 Million. Gavin held key software development and later product marketing roles as part of the Zyray Wireless team that developed a 3G cellular processor. Gavin holds 10 granted US patents.
ABOUT COOLEY
Cooley is the go-to law firm for companies developing cutting-edge technologies and has a long tradition of representing clients in a range of issues relating to AI and machine learning. We deploy a multidisciplinary team of lawyers with deep subject matter knowledge who understand the intricacies and complexities of large language models, machine learning and artificial intelligence technology.
ABOUT EVONEXUS
EvoNexus is California’s leading nonprofit technology startup incubator located in San Diego. EvoNexus has successfully incubated over 260 startups with a survival rate of over 85%. Since the incubator’s formation in 2010, EvoNexus companies have secured over $1.6B in venture funding, $10B in pre-exit valuation, and had over 45 acquisitions valued at over $2.1B. YTD $240M invested. EvoNexus is supported by corporate partners, including some of the largest multinational corporations in the world such as Qualcomm, Viasat, muRata, pSemi, and more! For more information, please visit evonexus.org.
Event Venue & Nearby Stays
Cooley LLP, 10265 Science Center Drive, San Diego, United States
USD 0.00
